Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,574
Closed -$467K 1470
2022
Q2
$467K Hold
8,574
﹤0.01% 1179
2022
Q1
$467K Buy
+8,574
New +$466K ﹤0.01% 1234
2014
Q3
Sell
-528
Closed -$35K 2305
2014
Q2
$35K Buy
+528
New +$35.7K ﹤0.01% 2160

Other funds holding GSK

Panagora Asset Management's GSK Position: Q3 2022 in Review

Panagora Asset Management sold out of GSK (GSK) in Q3 2022, closing a stake of 8,574 shares — an estimated $467K sold.

Panagora Asset Management first reported a position in GSK in Q2 2014 and held it in 3 quarters. The position peaked at $467K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Panagora Asset Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Panagora Asset Management sold 8,574 GSK shares in Q3 2022, an estimated $467K.
  • Panagora Asset Management first reported a position in GSK in Q2 2014 and held it in 3 quarters.
  • Panagora Asset Management's GSK position peaked at $467K in Q2 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.